Ametek (AME) Tops Q3 EPS by 8c

Ametek (NYSE: AME) reported Q3 EPS of $1.01, $0.08 better than the analyst estimate of $0.93. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.11 billion.

GUIDANCE:

Ametek sees Q4 2020 EPS of $1.00-$1.04, versus the consensus of $0.98.

For earnings history and earnings-related data on Ametek (AME) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c